Impedimed (IPD)

Download button icon Download

Impedimed (IPD): Signals

No data currently available.

data-ad-format="auto">

Explore Compare Share

TECHNICAL ANALYSIS SUMMARY


The opening and closing bar positions can add depth to assess whether buyers of sellers commitment is changing and thus which side is in control at the close of the trading session.

Calculation: Open Today Versus Close Today (OTCT):
1) If the market opens near the low and closes near the high the buyers have had control during the entire day;
2) If the market opens near the high and closes near the low the sellers have had control during the entire day;
3) If the market opens near one extreme of the range and closes near the middle of the range the side who started in control has lost commitment;
4) If the market opens near one extreme and closes near the same extreme the side who started in control has lost control;
5) If the market opens near the middle of the range and closes near one extreme control has swung to the buyers;
6) If the close is near the high and if the close is near the low the control has swung to the sellers;
7) If the market opens near the middle of the range and closes similarly neither side is strongly committed;


PROFILE: Impedimed (IPD.AX)


Stock Exchange: ASX
Company: Impedimed
Ticker Codes: | IPD.AX | ASX:IPD |

About Impedimed (ASX:IPD):

ImpediMed Limited, together with its subsidiaries, engages in the development, manufacture, and sale of bioimpedance devices and consumables in Australia, North America, Europe, and internationally. The company operates through Medical and Test & Measurement segments. It offers L-Dex U400, a technology that utilizes the characteristics of frequency dependent current flow to quantify changes in extracellular fluid in the patient's limb; and SFB7, a tetra polar bioimpedance spectroscopy device that scans various frequencies for the estimation of body composition in healthy individuals. The company also provides DF50, a single frequency body composition analysis in healthy individuals; and ImpediVET, a bioimpedance spectroscopy technology for use in veterinary applications. Its products are used in a range of applications, such as in the assessment and monitoring of secondary lymphedema, as well as monitoring of body composition and hydration. In addition, the company is involved in the supply of power precision testing and measuring equipment. ImpediMed Limited was founded in 1999 and is headquartered in Pinkenba, Australia.

Top 10:

Open vs Close

Download button icon Download
Company Close Change (%) Volume Value Signal
LYC Lynas Corporation 1.84 11.9 10,942,144 0 BULLISH
MVP Medical Developments 3.91 7.4 111,742 0 BULLISH
ISU Iselect 0.8 6.7 159,619 0 BULLISH
JIN Jin 9.83 6.3 1,252,407 1 BULLISH
SXY Senex Energy 0.36 4.3 2,229,926 0 BULLISH
ADA Adacel Technologies 0.74 4.2 69,085 1 BULLISH
IFN IFN 0.51 4.1 1,616,892 0 BULLISH
CNI Centuria Capital 1.41 4.1 235,309 0 BULLISH
GRR Grange Resources 0.27 3.8 5,166,553 1 BULLISH
LNG Liquefied Natural Gas 0.5 3.1 672,534 1 BULLISH
back to top